In contrast to its intrinsic non-proteolytic effect on EGFR activation and cell proliferation in 3D Matrigel, the enzymatic activity of MT4-MMP was still required for the early angiogenic switch during breast cancer progression [43]. Here, MT4 is linked to breast cancer.